V2X, Inc. (VVX)

NYSEIndustrialsAerospace & DefenseSnapshot 2026-10-23

$74.09+1.00%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge V2X, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.1%

+10% or more+5%0%−5%−10% or less

6.94 → 6.94 EPS · FY ending Dec 31, 2027 · 8 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 8 to 8; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2027-01-03
Revenue	—	1.25B
EPS	—	1.586
Annual ending 2026-12-31
Revenue	—	4.98B
EPS	—	6.226
Annual ending 2027-12-31
Revenue	—	5.24B
EPS	—	6.939

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Manage debt and credit agreements without harming financial health	A supporting condition in V2X, Inc.'s published investment case. The stated target is Maintain stable credit metrics and manageable debt levels.	Intact	Material credit deterioration or debt distress reported	Qualitative condition This condition has no defined numerical measure. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Net debt improved from $895.4M in 2026-Q1 to $876.1M in 2026-Q2, with net leverage ratio improving from 2.5x to 2.4x. Management reiterated target of approximately 2.0x net leverage by end of 2026, showing delivering progress on capital allocation. Delivery assessment Oct 24, 2026
Full-year 2026 EPS at or above $5.95 per share	EPS rises to nearly $6 per share.	Under Pressure	Full-year 2026 EPS falls below $4.65 per share	Diluted EPS: $0.81 per share FY2026-Q2; GAAP. Published target: >= $5.95 per share. Target period is not explicitly aligned with this observation. Source published Aug 3, 20260.81 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jul 3, 2026 Source: company_financial_results. Reference: 2de01f90-c35b-4fc7-a2d2-7bd19e216aa1. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Adjusted diluted EPS grew from $0.60 in 2026-Q1 to $0.81 in 2026-Q2. Management raised full-year 2026 EPS guidance twice, from $5.75-$6.15 to $5.90-$6.30, indicating delivering improved profitability and earnings growth. Delivery assessment Oct 24, 2026
Full-year 2026 revenue at or above $4.875 billion	A primary condition in V2X, Inc.'s published investment case. The stated target is >= $4.875 billion.	Under Pressure	Full-year 2026 revenue falls below $4.425 billion	Revenue: $1.257B FY2026-Q2; GAAP. Published target: >= $4.875 billion. Target period is not explicitly aligned with this observation. Source published Aug 3, 20261,256,643,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jul 3, 2026 Source: company_financial_results. Reference: 2de01f90-c35b-4fc7-a2d2-7bd19e216aa1. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Revenue grew from $1.0159B in 2026-Q1 to $1.2566B in 2026-Q2. Management increased full-year 2026 revenue guidance twice, from $4.825B-$4.975B to $4.875B-$5.025B, reflecting delivering strong topline growth and backlog. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$6.94

$6.77 → $6.94 · observed estimates

FY2027 revenue$5.24B

$5.18B → $5.24B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$6.77	$5,180,903,090	12 / 12
2026-07-25	$6.77	$5,180,903,090	12 / 12
2026-07-26	$6.77	$5,180,903,090	12 / 12
2026-07-27	$6.77	$5,180,903,090	12 / 12
2026-07-28	$6.77	$5,180,903,090	12 / 12
2026-07-29	$6.78	$5,195,191,308	8 / 9
2026-07-30	$6.79	$5,195,191,308	8 / 9
2026-07-31	$6.79	$5,195,191,308	8 / 9
2026-08-01	$6.79	$5,195,191,308	8 / 9
2026-08-02	$6.79	$5,195,191,308	8 / 9
2026-08-03	$6.79	$5,195,191,308	8 / 9
2026-08-04	$6.77	$5,180,903,090	12 / 12
2026-08-05	$6.77	$5,180,903,090	12 / 12
2026-08-06	$6.78	$5,197,679,280	12 / 12
2026-08-08	$6.92	$5,228,551,490	8 / 9
2026-08-09	$6.92	$5,228,536,490	12 / 12
2026-08-10	$6.92	$5,228,551,490	8 / 9
2026-08-12	$6.92	$5,228,551,490	8 / 9
2026-08-13	$6.92	$5,228,551,490	8 / 9
2026-08-14	$6.92	$5,228,551,490	8 / 9
2026-08-15	$6.92	$5,228,551,490	8 / 9
2026-08-16	$6.92	$5,228,551,490	8 / 9
2026-08-17	$6.92	$5,228,551,490	8 / 9
2026-08-18	$6.92	$5,228,551,490	8 / 9
2026-08-19	$6.92	$5,228,551,490	8 / 9
2026-08-20	$6.94	$5,235,244,490	8 / 9
2026-08-21	$6.94	$5,235,244,490	8 / 9
2026-08-22	$6.94	$5,235,244,490	8 / 9
2026-08-23	$6.94	$5,235,244,490	8 / 9
2026-08-24	$6.94	$5,235,244,490	8 / 9
2026-08-25	$6.94	$5,235,244,490	8 / 9
2026-08-26	$6.94	$5,235,244,490	8 / 9
2026-08-27	$6.94	$5,235,244,490	8 / 9
2026-08-28	$6.94	$5,235,244,490	8 / 9
2026-08-29	$6.94	$5,235,244,490	8 / 9
2026-08-30	$6.94	$5,235,244,490	8 / 9
2026-08-31	$6.94	$5,235,244,490	8 / 9
2026-09-01	$6.94	$5,235,244,490	8 / 9
2026-09-02	$6.94	$5,235,244,490	8 / 9
2026-09-03	$6.94	$5,235,244,490	8 / 9
2026-09-04	$6.94	$5,235,244,490	8 / 9
2026-09-05	$6.94	$5,235,244,490	8 / 9
2026-09-06	$6.94	$5,235,244,490	8 / 9
2026-09-07	$6.94	$5,235,244,490	8 / 9
2026-09-08	$6.90	$5,232,780,577	8 / 9
2026-09-09	$6.90	$5,232,780,577	8 / 9
2026-09-10	$6.90	$5,232,780,577	8 / 9
2026-09-11	$6.90	$5,232,780,577	8 / 9
2026-09-12	$6.90	$5,232,780,577	8 / 9
2026-09-13	$6.90	$5,232,780,577	8 / 9
2026-09-14	$6.90	$5,232,780,577	8 / 9
2026-09-15	$6.90	$5,232,780,577	8 / 9
2026-09-16	$6.90	$5,232,780,577	8 / 9
2026-09-17	$6.90	$5,232,780,577	8 / 9
2026-09-18	$6.94	$5,235,244,490	8 / 9
2026-09-19	$6.94	$5,235,244,490	8 / 9
2026-09-20	$6.94	$5,235,244,490	8 / 9
2026-09-21	$6.94	$5,235,244,490	8 / 9
2026-09-22	$6.94	$5,235,244,490	8 / 9
2026-09-23	$6.94	$5,235,244,490	8 / 9
2026-09-24	$6.94	$5,235,244,490	8 / 9
2026-09-25	$6.94	$5,235,244,490	8 / 9
2026-09-26	$6.94	$5,235,244,490	8 / 9
2026-09-27	$6.94	$5,235,244,490	8 / 9
2026-09-28	$6.94	$5,235,244,490	8 / 9
2026-09-29	$6.94	$5,235,244,490	8 / 9
2026-09-30	$6.94	$5,235,244,490	8 / 9
2026-10-01	$6.94	$5,235,244,490	8 / 9
2026-10-02	$6.94	$5,235,244,490	8 / 9
2026-10-03	$6.94	$5,235,244,490	8 / 9
2026-10-04	$6.94	$5,235,244,490	8 / 9
2026-10-05	$6.94	$5,235,244,490	8 / 9
2026-10-06	$6.94	$5,235,244,490	8 / 9
2026-10-07	$6.94	$5,235,244,490	8 / 9
2026-10-08	$6.94	$5,235,244,490	8 / 9
2026-10-09	$6.94	$5,241,982,295	8 / 9
2026-10-10	$6.94	$5,241,982,295	8 / 9
2026-10-11	$6.94	$5,241,982,295	8 / 9
2026-10-12	$6.94	$5,241,982,295	8 / 9
2026-10-13	$6.94	$5,239,895,545	8 / 9
2026-10-14	$6.94	$5,239,895,545	8 / 9
2026-10-15	$6.94	$5,239,895,545	8 / 9
2026-10-16	$6.94	$5,239,895,545	8 / 9
2026-10-17	$6.94	$5,239,895,545	8 / 9
2026-10-18	$6.94	$5,239,895,545	8 / 9
2026-10-19	$6.94	$5,239,895,545	8 / 9
2026-10-20	$6.94	$5,239,895,545	8 / 9
2026-10-21	$6.94	$5,239,895,545	8 / 9
2026-10-22	$6.94	$5,239,895,545	8 / 9
2026-10-23	$6.94	$5,239,895,545	8 / 9
2026-10-24	$6.94	$5,239,895,545	8 / 9

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	7	4	1
2026-06-01	7	5	1
2026-07-01	6	5	1
2026-08-01	6	6	1
2026-09-01	5	6	1
2026-10-01	5	6	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 5 Buy / Strong Buy · 6 Hold · 1 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Manage debt and credit agreements without harming financial healthQualitative condition
Full-year 2026 EPS at or above $5.95 per sharePublished status: Under Pressure
Full-year 2026 revenue at or above $4.875 billionPublished status: Under Pressure

Next proof point

Nov 2, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.5%Typical daily move · historical

Downside history

-25.0%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

V2X, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

VVX is an execution-dependent industrials business, with a thesis supported by recent growth and improved guidance rather than a clearly durable earnings record. The long-term thesis is intact, but risk has risen from moderate to elevated and earnings quality is rated fragile.

What's priced into V2X, Inc.

VVX is described as cheap versus peers, while its valuation model also shows a 43% premium versus peers, so the relative valuation signals are mixed. The expectations gap is negative, and the evidence says fragility is low because weak execution quality is not combined with the full set of expensive valuation and turbulent-regime risks.

What the fundamentals likely do

Near term, recent results show revenue and adjusted diluted earnings per share rising from the first to the second quarter of 2026, and management has raised full-year revenue and earnings guidance twice. Debt and leverage have improved, though capital allocation remains mixed against the stated year-end leverage goal; the near-term miss risk is rated low, with a past deep miss still a caution.

What V2X, Inc. hinges on

For the multi-year view, continued delivery against raised guidance matters, especially because a reversal and guidance cut would damage management credibility. The sector backdrop is a headwind, so results and guidance from industrial bellwethers could either support sector momentum or remove that support. The CEO transition is noted, but the evidence gives little detail on its effect.